Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-06-16

European human embryonic stem cell registry

Objectif

Human embryonic stem cell (hESC) research holds promise for the development of therapies for degenerative pathologies, offers a tool for drug discovery and toxicity tests, for studying human development, disease physiology and gene control. hESC lines are currently derived in an increasing number of laboratories in Europe and around the world. A detailed registry of available cell lines will promote the validation and efficient use of these precious cells for research and application.

Comparable information is needed about the origin of the cell lines, the methodology and standards for their derivation and the characteristics to assess their availability for research and future therapies. The growing use of hESC by the scientific community demands a high quality and comprehensive registry. The aim of the proposed European hESC registry is to promote access to all hESC lines derived in Europe and transparency about their characteristics.

Appel à propositions

FP6-2005-LIFESCIHEALTH-6
Voir d’autres projets de cet appel

Régime de financement

SSA - Specific Support Action

Coordinateur

CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN
Contribution de l’UE
Aucune donnée
Coût total
Aucune donnée

Participants (13)